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Objectives. The purpose of this study was to determine, in a 
large referral population, the rate of echocardiographic change in 
mitral valve area (MVA) without interim intervention, to deter- 
mine which factors influence progression of narrowing and to 
examine associated changes in the right side of the heart. 
Background. Little information is currently available on the 
echocardiographic progression of mitral stenosis, particularly on 
progressive changes in the right side of the heart and the ability 
of a previously proposed algorithm to predict progression. 
Methods. We studied 103 patients (mean age 61 years; 74% 
female) with serial two-dimensional and Doppler echocardiogra- 
phy. The average interval between entry and most recent follow-up 
study was 3.3 -+ 2 years (range 1 to 11). 
Results. During the follow-up eriod, MVA decreased ata mean 
rate of 0.09 cm2/year. In 28 patients there was no decrease, in 40 
there was only relatively little change (<0.1 cm2/year) and in 35 
the rate of progression of mitral valve narrowing was more rapid 
(>0.1 cm2/year). The rate of progression was significantly greater 
among patients with a larger initial MVA and milder mitral 
stenosis (0.12 vs. 0.06 vs. 0.03 cm2/year for mild, moderate and 
severe stenosis, p < 0.01). Although the rate of mitral valve 
narrowing was a weak function of initial MVA and echocardio- 
graphic score by multivariate analysis, no set of individual values 
or cutoff points of these variables or pressure gradients could 
predict his rate in individual patients. There was a significant 
increase in right ventricular diastolic area (17 to 18.7 cm 2) and 
tricuspid regurgitation grade (2 + to 3 +; p < 0.0001 between entry 
and follow-up studies). Progression in right heart disease oc- 
curred even in patients with minimal or no change in MVA. 
Patients with associated aortic regurgitation had a higher ate of 
decrease in MVA than did those with trace or no aortic regurgi- 
tation (0.19 vs. 0.086 cm2/year, p < 0.05). 
Conclusions. The rate of mitral valve narrowing in individual 
patients is variable and cannot be predicted by initial MVA, mitral 
valve score or transmitral gradient, alone or in combination. 
Right heart disease can progress independent of mitral valve 
narrowing. 
(J Am Coll Cardiol 1996;28:472-9) 
Several clinical studies from the presurgical era have shown 
that the rate of progression of rheumatic mitral stenosis varies 
widely among patients (1-3). Although clinical progression has 
been thoroughly investigated, there is little information cur- 
rently available regarding the echocardiographic progression 
of mitral stenosis and mitral valve area as such. Only one 
previous echocardiographic study (4) investigated the rate of 
mitral valve narrowing and the factors that influence it in 50 
patients (16 with progressive narrowing). That study proposed 
that progression could be predicted by mitral valve echocar- 
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diographic score and transmitral gradient, with implications 
for the frequency of follow-up and prognosis. However, that 
predictive algorithm has not been subsequently confirmed in 
another patient group, and mitral valve area (MVA) in that 
study was determined by the indirect pressure half-time 
method, which is affected by factors other than MVA (5,6). 
Although the hemodynamic consequences of mitral stenosis 
affect mainly the pulmonary vascular bed and right side of the 
heart, there are no available data obtained with two- 
dimensional nd Doppler color flow echocardiography regard- 
ing the rate of progression of right heart and pulmonary 
vascular disease. Such data are important because clinical 
deterioration may reflect changes in the right-sided response 
to mitral stenosis unrelated to changes in mitral valve area. 
The purpose of the present study, therefore, was 1) to 
determine the rate of change in mitral valve area in the 
absence of intervention by using direct wo-dimensional echo- 
cardiographic planimetry and the pressure half-time method in 
a large referral population with mitral stenosis (never studied 
before by planimetry); 2)to determine which factors influence 
progression of mitral valve narrowing; and 3) to determine 
which changes occur in right atrial, annular and ventricular size 
and function, including tricuspid regurgitation and pulmonary 
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hypertension, as a function of the progression of mitral steno- 
sis. 
Methods  
Study patients. Between 1983 and 1993, a total of 118 
patients with mitral stenosis had an entry and follow-up 
two-dimensional echocardiogram with a ->l-year follow-up 
interval and without interim intervention (surgical or percuta- 
neous valvulotomy). Of these patients, 103 had a rheumatically 
deformed mitral valve and measurable MVA by either planim- 
etry, pressure half-time method, or both, and were retrospec- 
tively reviewed. There were 76 women (74%) and 27 men 
(26%); the mean age was 61 _+ 16 years (range 22 to 84). The 
average interval between entry and most recent follow-up 
echocardiographic study was 3.3 _+ 2 years (range 1 to 11). Two 
patients had had commissurotomy before their initial study 
and none had had previous percutaneous valvulotomy. 
Echocardiographic analysis. A complete two-dimensional 
and Doppler echocardiographic examination was performed 
by using a Hewlett-Packard ultrasound imager with a 2.5-MHz 
phased array transducer. Mitral valve area was assessed by 
both direct planimetry (7) and the pressure half-time method 
(8) whenever possible. With the short-axis view, care was taken 
to scan the mitral valve from tips to base to obtain the smallest 
valve orifice in early diastole. Transmitral inflow velocities 
were recorded by Doppler echocardiography from the apical 
four-chamber view. Valve areas were measured by using an 
average of five beats during sinus rhythm and seven during 
atrial fibrillation. Studies were reviewed and measured by one 
trained observer who did not know whether astudy was initial 
or follow-up. Doppler spectra were traced and analyzed to 
determine peak and mean transmittal gradients. Mitral valve 
area assessment a entry and follow-up study was available by 
planimetry in92 patients and by the pressure half-time method 
in the remaining 11 (evenly distributed over the range of values 
for mitral valve area decrease/year). Mitral valve area by the 
pressure half-time method was available in a total of 51 
patients (the 11 with pressure half-time only and 40 more) so 
that both planimetry and half-time areas at entry and follow-up 
were available for comparison in 40 patients. A previously 
described semiquantitative echocardiographic assessment of 
mitral valve score (9) was obtained in each patient at entry by 
assigning a value of 0 to 4 (with increasing abnormality) to 
each of four morphologic characteristics of the valve: leaflet 
mobility, thickening, calcification and subvalvular thickening. 
The presence of mitral regurgitation on the initial study was 
assessed with pulsed Doppler study or color flow mapping, or 
both. The severity of regurgitation was evaluated in multiple 
views and graded from 0 to 4+ (severe) according to jet 
penetration i to the left atrium (10,11). The presence and 
severity of aortic regurgitation (grade 0 to 4) was judged from 
the ratio of cross-sectional area of the proximal regurgitant jet 
and left ventricular outflow tract, as previously described (12). 
The progression of both mitral and aortic regurgitation was 
analyzed in patients in whom Doppler flow mapping was 
available both at entry and follow-up studies (43 with mitral, 44 
with aortic regurgitation). 
Right heart measurements. Echocardiographic images 
were obtained uring quiet end-expiration i a standard apical 
four-chamber view optimized to obtain the longest right ven- 
tricular long-axis and its largest short-axis diameters at the 
base and midventricular level, with the greatest visualized 
excursion of the tricuspid leaflets (13,14). The right ventricular 
end-systolic and end-diastolic avity areas were traced in the 
same view, and the percent change in area was calculated. The 
maximal diastolic tricuspid annulus diameter was measured 
from insertion of the septal to insertion of the anterior 
tricuspid leaflet. Right ventricular systolic pressures were 
estimated by continuous wave Doppler study by using the 
modified Bernoulli equation (4 x [peak tricuspid regurgitation 
velocity]Z), adding 10 mm Hg for the estimated right atrial 
pressure (15-18). 
Tricuspid regurgitation was evaluated inmultiple views and 
graded from 0 to 4+ by integrating both Doppler extent of the 
regurgitant jet and evidence of systolic flow reversal in the 
inferior vena cava or hepatic veins (18). Regurgitation was 
graded as trace [1] if jet area occupied <10% of right atrial 
area; mild [2] if it occupied <20%; moderate [3] if it occupied 
20% to <33%; and severe [4] if it occupied ~33%, on the basis 
of reported correlations with surgical and angiographic data 
(19-21). If the ratio of jet area to right atrial area was close to 
a cutoff point, jet eccentricity increased the grade to the next 
higher value because ccentric wall jets appear smaller than 
comparable free jets (22,23). Systolic flow reversal in the 
inferior vena cava or hepatic veins by pulsed Doppler echo- 
cardiography was considered to indicate at least moderate 
regurgitation regardless of the other findings (20). 
Data analysis. Data were expressed as mean value _+ SD. 
Entry and follow-up data were compared by two-way repeated 
measures analysis of variance by using the statistical program 
BMDP 4V (BMDP Statistical Software, 1993), with multiple 
comparisons protection by means of an overall T 2 test. This 
analysis was also used to compare changes in right heart 
measurements in the group with progression of stenosis (de- 
crease in MVA ->0.1 cm2/year) and the group without progres- 
sion (decrease inMVA <0.1 cm2/year, see later). Missing data 
were filled in as necessary by the BMDPAM statistical routine. 
Multiple stepwise linear regression analysis was performed to 
identify predictors for the rate of decrease in MVA/year. 
The variables initially entered into the model were age, 
gender, initial MVA, mitral valve morphologic score, peak and 
mean transmitral gradients, degree of mitral regurgitation, left 
atrial size and prior commissurotomy. The univariate correla- 
tion coefficients for these variables were determined and were 
also entered into a multivariate model for predicting the rate 
of change of MVA with use of the RS1 statistical package 
(Bolt, Beranek and Newman, 1993). Forward stepping was 
used, with the F to enter and F to remove any variable selected 
so that the corresponding significance l vel (outer tail area) 
was <0.05; no variables were forced into the model. The same 
set of variables was also used to identify predictors for the rate 
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Table 1. Characteristics of 103 Study Patients at Entry and 
at Follow-Up -~ 
Follow-Up p 
Entry (mean 3.3 yr) Value 
Age (yr) 61 + 16 64 _+ 16 .~ 
Female 76 (74%) 76 (74%) ~, 
Atrial fibrillation 48 (47%) 51 (50%) NS % 
Heart rate (beats/rain) 75 + 15 73 + 14 NS ;> 
Mitral valve area (cm 2) 1.7 _+ 0.6 1.4 _+ 0.6 0.00005 o 
Peak mitral gradient (mm Hg) 14.0 +_ 6 14.5 _+ 7 NS 
Mean mitral gradient (ram Hg) 6.4 +~ 3.3 6.7 _+ 3,1 NS 
Left atrial dimension (cm) 5.0 +~ 10 5.1 _+ 11 NS 
Mitral regurgitation (0 to 4+) 1.8 _+ 0.8 2.3 +_ 0.8 0.00005 
Data presented are mean value _+ SD or number (%) of patients. 
of change in right heart size in terms of univariate correlation 
coefficients and multiple stepwise linear regression analysis, as 
before; analysis was repeated by excluding four patients with 
images suggesting the possibility of organic tricuspid valve 
disease (one with mild doming tricuspid stenosis and three 
with leaflet thickening). Right ventricular systolic pressure 
from tricuspid regurgitant velocities could not readily be 
included in the model for right heart size because of a large 
number of missing values (no regurgitation or insufficient 
signal). 
Results 
Characteristics of study patients at entry and at follow-up 
(Table 1). Over the follow-up period (mean 3.3 years, range 
1 to 11) there were a significant decrease in MVA (1.69 to 
1.45 cm 2, p < 0.00005) and an increase in mitral regurgitation 
grade by Doppler color flow mapping (1.8 to 2.4 [out of 4+], 
p < 0.00005); however, there were no significant changes in 
peak or mean transmitral gradient, frequency of atrial fibrilla- 
tion, heart rate or left atrial size (p > 0.20). 
Determinants of mitral valve narrowing. The mean rate of 
mitral valve narrowing was 0.09 _+ 0.13 cm2/year. Examination 
of the individual data (Fig. 1) shows that the rate of decrease 
in MVA was variable. In 28 patients there was no decrease in 
area over a mean follow-up period of 3.3 years; in 40 there was 
only a slight change (<0.1 cm2/year) and in 35 the rate of 
0.8 
Nonprogressive o.7 
o Progress ve 0.6 
0.5 
0.4 
0.3 j 
0.2 
0.1 
0 
-0.1 
-0.2 
10' 20' 30 46 50 60 7; 8; 90 100 
Ranked Patient Order 
Figure 1. Rate of decrease inmitral valve area (patient rank order) for 
all 103 patients studied. Patients were stratified into two groups: 
progressive disease (open circles: valve narrowing ->0.1 cm2/year, n = 
35\and nonprogressive disease (dosed circles: valve narrowing <0.1 
cm"/year, n = 68). sq. = square. 
progression of narrowing was more rapid (->0.1 cm2/year [4]). 
The rate of progression was significantly greater among pa- 
tients with a larger initial MVA. It was 0.12 cm2/year in the 61 
patients with mild mitral stenosis (valve area >1.4 cm2), 0.06 
cm2/year in the 29 patients with moderate stenosis (valve area 
1.0 to 1.4 cm 2) and 0.03 cm2/year in the 13 patients with severe 
stenosis (valve area <-1.0 cm 2, p < 0.05 for mild vs. moderate 
or severe mitral stenosis). Figure 2 shows the progression of 
mitral stenosis in patients with different degrees of stenosis. 
Overall, 19% of the study patients had an increase of at least 
one grade in the severity of mitral stenosis over the follow-up 
period. There was no significant difference in the rate of 
progression between patients >50 or <50 years old, men or 
women, patients with sinus rhythm or atrial fibrillation, echo- 
cardiographic score >8 or <8, or entry mitral regurgitation 
grade ->2+ or <2+ (Fig. 3). 
In a univariate analysis only initial MVA was weakly 
correlated (r = 0.4) with the rate of decrease in MVA (p < 
0:001). The univariate correlation coefficients of the variables 
entered into the model were as follows: age = 0.07, mitral 
valve score = 0.23, gender = -0.013, peak transmitral gradi- 
ent = 0.026, mean transmitral gradient = -0.011, degree of 
mitral regurgitation = -0.09, left atrial size = -0.18; prior 
(> 1.4 sq. era) 
(I to 1.4 sq. era) L ~  ~ ~  L l 
Severe MS 24 
.(5 !.0 sq.cm) 
Entry Follow-up 
No Change in Grade = 81% 
Increase in Grade=l 9% 
Figure 2. Changes in mitral stenosis (MS) grade in 103 
patients over a mean period of 3.3 years. A change in grade 
required a ->0.3-cm z decrease in mitral valve area over the 
follow-up period, sq. = square. 
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Figure 3. Rate of change in mitral 
valve area (MVA, cm2Pyear) in re- 
lation to age, gender, cardiac 
rhythm, mitral valve area, echocar- 
diographic score and mitral (MR) 
and aortic (AR) regurgitation 
grade. AF = atrial fibrillation; F = 
female; M = male; sq. : square. 
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commissurotomy = -0.12. The rate of change of MVA 
normalized to initial MVA did not significantly correlate with 
initial MVA. In multivariate regression analysis, initial mitral 
valve area and echocardiographic s ore emerged as weak 
predictors for the rate of decrease in MVA/year, but their 
overall combined predictive power was low: Only 22% of the 
change in MVA/year could be explained by these two variables 
(r 2 = 0.22), Furthermore, no single value for initial MVA, 
echocardiographic score or gradient or combination of such 
values could separate the groups with and without progression 
or allow confident prediction of changes in MVA in any 
individual patient. 
Planimetry versus pressure half-time determination of 
MVA. In 40 patients both planimetry and pressure half-time 
methods for assessing MVA were available at entry and 
follow-up studies. There was strong correlation between 
planimetry and Doppler-determined MVA (r = 0.94), and the 
rate of decrease in MVA was almost identical (planimetry 
0.8 cm2/year, pressure half-time 0.82 cruZ/year) in these pa- 
tients. Mitral valve area was available for both entry and 
follow-up studies in 51 patients by the pressure half-time 
method and in 92 patients by planimetry. Separate univariate 
and multiple stepwise linear regression analysis performed by 
using the data based on the Doppler method alone (n = 51) or 
planimetry alone (n = 92) provided essentially the same results 
as those for the entire group (n = 103). Although initial MVA 
and echocardiographic score made weak contributions to the 
rate of change in MVA/year, progression in the individual 
patient could not be predicted by any entry demographic or 
echocardiographic variable regardless of the method (planim- 
etry or pressure half-time) used to assess MVA. 
Mitral regurgitation. At entry, 55 patients (53%) had no or 
trace mitral regurgitation, 25 (24%) had mild and 23 (23%) 
had moderate mitral regurgitation. The mean mitral regurgi- 
tation grade (0 to 4+) significantly increased between entry 
and follow-up study (1.8 + 0.7 vs. 2.4 _+ 0.85, p < 0.001). In the 
43 patients with available color flow assessment of mitral 
regurgitation, regurgitation did not change in 17 (40%), in- 
creased by one grade in 23 (53%), by two grades in 2 (5%) and 
by three grades in only 1 patient (2%). In multivariate analysis 
only initial MVA and mitral regurgitation grade were signifi- 
cant predictors of progressive mitral regurgitation. 
Progression of right heart disease (Tables 2 and 3). Over 
the follow-up period there was a significant increase in right 
ventricular systolic and diastolic areas, right atrial area, tricus- 
pid annulus diameter, tricuspid regurgitation grade and 
Doppler-derived right ventricular systolic pressure (p < 0.001 
for all comparisons, Table 2). Significant changes in right heart 
measurements were found in the groups with and without 
progression (Table 3). The rate of change of tricuspid regur- 
gitant jet area divided by right atrial area was significantly 
higher in the group with progression versus nonprogression 
(29%/year vs. 6%/year, p < 0.00005). Significant changes over 
the follow-up period also occurred in the 28 patients with 
unchanged MVA over time, with right ventricular diastolic 
area increasing from 16.6 _+ 4.4 to 18.8 _+ 5 cm 2 (p = 0.02), 
Table 2. Right Heart Measurements of Study Patients at Entry and 
at Follow-Up 
Follow-Up p 
Entry (mean 3.3 years) Value 
RV end-systolic area (cm z) 9.4 _+ 3.6 10.6 _+ 4 0.00005 
RV end-diastolic area (cm 2) 17 _+ 5 18.7 _+ 6 0.0001 
RV area change (%) 45 + 9 44 _+ 9 0.2 
RA area (cm 2) 16.4 _+ 7 19.3 _+ 8 0.00005 
Annular diameter (cm) 3.4 _+ 0.6 3.6 _+ 0.6 0.001 
TR grade (1-3) 2.0 _+ 1.3 3.0 + 1.7 0.00005 
RV systolic pressure (mm Hg) 42.9 _+ 12 48.7 + 16 0.001 
Data presented are mean value -+ SD, RA = right atrial; RV = right 
ventricular; TR = tricuspid regurgitation. 
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Table 3. Changes inRight Heart Measurements From Entry to Follow-Up in the Groups With Progression a d Nonprogression of Disease 
Progression (n = 35) Nonprogression ( = 68) 
No. Entry Follow-Up No. Entry Follow-Up 
RV end-systolic area (cm z) 33 9.6 + 3.8 10.9 ± 4.6-~ 63 9.3 _+ 3.4 10.4 +_ 5.3t 
RV end-diastolic area (cm 2) 32 17.6 + 5.9 19.6 + 7.4* 62 16.6 ± 4.6 18.2 _+ 5.3? 
RV area change (%) 32 45.0 ± 9 43.1 +_ 9 62 44.8 +_ 9 44.1 _+ 9 
RA area (cm 2) 33 16.7 _+ 7 18.1 ± 8* 63 16.2 ± 6 19.9 _+ 8.5? 
Annular diameter (cm) 33 3.4 ± 0.6 3.6 ± 0.7 63 3.4 = 0.6 3.56 ± 0.6? 
RV systolic pressure (mm Hg) 12 43.9 ± 11 51 - 171" 31 42.1 ± 12 46 ± 14 
TR jet area (cm 2) 10 5.2 ± 4.2 8.9 ± 8~" 21 4.1 _+ 3.2 6.0 -+ 5.5] 
JA/RAA ratio 10 31 ± 16% 49 ± 23%? 21 25 ± 15% 30 ± 15%? 
*p < 0.05, tP < 0,01 between entry and follow-up study. Data presented are mean value + SD or number of patients. JA = jet area; RAA = right atrial area; 
other abbreviations as in Table 2. 
right atrial area from 16.5 ± 4.5 to 19.1 ± 6.7 cm z (p = 0.04) 
and tricuspid regurgitant jet area from 3.8 _+ 2.4 to 5.2 ± 
3.6 cm 2 (p = 0.02). 
The changes in right heart measurements at entry and 
follow-up were also evaluated in relation to mitral stenosis 
severity. Although at entry, right ventricular chamber size, 
systolic pressure and severity of tricuspid regurgitation were 
higher for patients with severe versus mild mitral stenosis, they 
increased from entry to follow-up study in patients with all 
degrees of mitral stenosis. For example, even in patients with 
mild stenosis, right ventricular end-diastolic area increased 
from 16.6 + 5 to 17.7 _+ 6 cm 2, right atrial area from 15 ± 6 to 
18 ± 8 cm 2 and tricuspid regurgitant jet area from 4.1 ± 2.1 to 
7.4 ± 5.3 cm 2 (p < 0.05). 
Both univariate and multiple stepwise linear regression 
analyses identified the change in mean transmitral gradient as 
the only significant predictor for the rate of increase in right 
ventricular end-diastolic area (r = 0.4, p < 0.006) and decrease 
in right ventricular area change (r = 0.5, p < 0.001). Age, 
gender, initial MVA, change in MVA and mitral valve score 
did not emerge as independent predictors for progression of 
right heart disease. Repeating the analysis excluding the four 
patients with echocardiographic evidence of possible organic 
tricuspid valve disease did not change the predictors identified 
by these analyses. 
Aortic regurgitation. At entry, 68 patients (66%) had no or 
trace aortic regurgitation, 25 (24%) had mild, 9 (9%) had 
moderate and 1 (1%) had severe aortic regurgitation. I  the 44 
patients with available Doppler color flow assessment ofaortic 
regurgitation both at entry and follow-up studies, regurgitation 
severity did not change in 35 patients (80%) and increased by 
one grade in 9 (20%). The rate of decrease of mitral valve area 
determined by planimetry over the follow-up period was 
significantly higher in patients with mild, moderate or severe 
aortic regurgitation than in patients with trace or no regurgi- 
tation (0.19 2 0.24 vs. 0.086 + 0.11 cm2/year, p < 0.05) (Fig. 3). 
Discuss ion  
The present study provides important information regard- 
ing three aspects of the progression of mitral stenosis in the 
absence of intervention: mitral valve narrowing, progression of 
right heart disease and the influence of associated valvular 
lesions. It does so in the largest reported patient group studied 
by echocardiography with relatively long-term follow-up. 
Determinants of mitral valve narrowing. Mitral valve area 
in these patients decreased ata mean rate of 0.09 cm2/year, but 
the rate of progression of disease varied among patients. Some 
patients had progression from mild to critical mitral stenosis 
over several years, but others remained instable condition over 
a long period of time. More than two thirds had minimal or no 
change in MVA over several years, whereas one third (34%) 
had a more progressive course. The rate of mitral valve 
narrowing could not be predicted by several variables included 
in the multivariate analysis. Although the rate of mitral valve 
narrowing was a weak function of initial MVA and mitral valve 
score (and only initial MVA by the less sensitive univariate 
analysis), no set of individual or cutoff values could predict he 
rate of progression in the individual patient. 
These results agree with some of the findings but contrast 
with others reported by Gordon et al. (4) in a similar echocar- 
diographic study of 50 patients with mitral stenosis over a 
mean period of 3.5 years. In that study, MVA was determined 
by the indirect pressure half-time method, which is affected by 
factors other than valve area (5,6). The mean rate of mitral 
valve narrowing and the percent of those with progressive 
versus nonprogressive disease (defined the same way as in our 
study) were remarkably similar to our findings. However, their 
finding that patients whose valve disease progresses more 
rapidly are those with a higher mitral valve score and transmi- 
tral gradient was not supported inour study. We found that no 
set of individual or cutoff values could predict the rate of 
decline in MVA in the individual patient and we observed no 
significant differences in mitral valve score or transmitral 
gradient between the groups with and without progression of 
disease. These differences cannot readily be explained on the 
basis of different methods used to measure MVA (planimetry 
in the majority of our patients vs. pressure half-time), because 
separate analyses performed in 51 of our patients with MVA 
determined by the pressure half-time method, and 92 patients 
with MVA determined by planimetry provided essentially the 
same results as those of the overall analysis of all 103 patients. 
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It may be that the smaller number of patients in the study of 
Gordon et al. (4), particularly in the group with progression 
(16 in their study vs. 35 in ours), may account for differences in 
ability to predict progression. 
The variable rate of mitral valve narrowing is also in accord 
with the classic clinical natural history studies of Olesen (1) 
and Rowe et al. (2), who showed that, as judged by symptoms 
and clinical course, disease progression varies widely among 
patients. For example, Rowe et al. found that during a 10-year 
period, 40% of patients died and the condition of 40% 
remained unchanged. In 20 years, 80% died and 13% had no 
change in condition. Our findings are also comparable tothose 
of Dubin et al. (24), who similarly found two subgroups of 
patients with and without progression of disease based on 
hemodynamic studies (catheterization-derived MVA) and re- 
ported a rate of mitral valve narrowing in their group with 
progression similar to that in our patients with progression. 
Leutenegger tal. (25), who followed up 13 patients with mild 
mitral stenosis using M-mode echocardiographic indexes to 
assess MVA, also identified a subgroup (23%) with a more 
progressive course. 
Despite an overall significant decrease in mitral valve area 
in our patients, there were no significant changes in peak or 
mean transmitral gradient, findings that are in accord with 
those of Gordon et al. (4). The level of left atrial pressure, and 
therefore the gradient, isalso influenced by factors other than 
the severity of mitral stenosis, such as cardiac output, heart 
rate, atrial size and compliance, as well as blood volume 
(influence of diuretic drugs). This may explain why there was 
no increase in transmitral gradient associated with the de- 
crease in MVA. 
The observation that patients with mild stenosis had more 
rapid progression than those with severe stenosis raises some 
interesting pathophysiologic questions regarding progressive 
mitral valve narrowing, for which two mechanisms have been 
proposed (26): 1) a continuing rheumatic process with either 
repetitive rheumatic insults or a "smoldering" chronic rheu- 
matic activity; or 2) a nonspecific process, particularly late in 
the disease, resulting from trauma to the valve caused by 
altered flow patterns, analogous to the mechanism suggested 
for calcific aortic stenosis (27). It may be that the patients in 
our study with a severely narrowed mitral valve did not have 
rapid progression simply because most of the damage to the 
valve had already been done and not much tissue was available 
for further damage; on the other hand, in patients with mild or 
moderate mitral stenosis, even a mild degree of narrowing 
might be sufficient to alter flow patterns so as to traumatize the 
valve leaflets and lead to further thickening, fibrosis and 
calcification. Because our patients had a mean age of 61 years, 
we believe that most of the progression is more likely to be 
attributable tothe nonspecific process resulting from trauma to 
the valve rather than to a continuing rheumatic process. 
Progression of right heart disease. Although the hemody- 
namic consequences of mitral stenosis affect mainly the right 
side of the heart as mediated by pulmonary vascular disease, 
there are few reported ata regarding the changes in right 
heart size and function and the progression of associated 
tricuspid regurgitation i  mitral stenosis. This lack may relate 
to technical difficulties in evaluating right ventricular size and 
function and tricuspid regurgitation bycontrast angiography as 
well as the limitation of the technique for repeated follow-up 
(28). Therefore, echocardiography, especially when integrating 
information from two-dimensional, pulsed and color Doppler 
techniques, provides a readily available tool to assess the 
progression of right heart disease noninvasively. In this study 
there was significant progression in pulmonary hypertension 
and tricuspid regurgitation, gradual increase in right heart size, 
and slight decrease in right ventricular function over time. 
However, progression in right heart disease occurred even in 
patients with minimal or no change in MVA. Additionally, 
severe pulmonary hypertension (->60 mm Hg) developed in 
some patients with severe mitral stenosis (MVA -<1.0 cm2), 
whereas milder pulmonary vascular disease occurred in others. 
This phenomenon is well recognized: For unknown reasons, 
reactive pulmonary hypertension (and as a consequence right 
heart failure) is more likely to develop in some patients with 
tight mitral stenosis than in others (29). Mean transmitral 
gradient, which reflects changes in the severity of valve nar- 
rowing as well as cardiac output and left atrial compliance, was 
the only predictor for changes in right ventricular size and 
function by multivariate linear regression analysis. The mean 
gradient also causes increases in pulmonary artery pressure; 
however, pulmonary artery pressure, an important determi- 
nant of right ventricular decompensation, could not readily be 
entered into the model for right heart changes because of a 
large number of missing values (no or insufficient signal of 
tricuspid regurgitation). 
Influence of associated aortic regurgitation. Although aor- 
tic regurgitation is commonly associated with rheumatic mitral 
stenosis (30), there is no available information regarding its 
influence on the progression of mitral stenosis. By Doppler 
color flow mapping, 25% of our study patients initially had 
associated mild or moderate aortic regurgitation that increased 
to 30% (mild 18%, moderate 12%) at follow-up. An observa- 
tion not previously shown was that patients with associated 
aortic regurgitation had a higher rate of decrease in MVA 
(0.19 vs. 0.086 cm2/year, p < 0.05) than did those with trace or 
no aortic regurgitation. Two explanations are possible: 1) 
Associated aortic regurgitation is a marker for more severe 
rheumatic disease; and 2) the continuous hemodynamic stress 
on the anterior mitral leaflet from the aortic regurgitant jet 
may accelerate he damage to the mitral eaflet and may cause 
a more rapid rate of valve narrowing. 
Study limitations. The method used for MVA assessment 
in the majority of patients was echocardiographic planimetry. 
Although this method is not always obtainable with ideal 
quality imaging, it has been confirmed to provide accurate data 
by comparison with invasive and necropsy measurements 
(7,29,31) and to be feasible in up to 96% of patients with 
rheumatic mitral stenosis (13). We therefore xcluded those 
patients (n = 11) in whom the image quality of the mitral valve 
limited such measurement. The advantage of using direct 
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planimetry isthat it is not affected by factors uch as heart rate, 
error in cardiac output measurement and mitral and aortic 
regurgitation. 
This study used the same design as that recently reported by 
Gordon et al. (4) and was therefore able to test their proposed 
algorithm for predicting progression, adding MVA by planim- 
etry in a larger number of patients. Gordon et al. commented 
that all such retrospective follow-up studies may possibly select 
patients with less severe disease because those with severe 
disease are more likely to undergo intervention; the results will 
then be the lower limits to the rate of mitral stenosis progres- 
sion. We have therefore carefully stated that the purpose of 
our study was to examine patients without interim interven- 
tion, to whom the results apply most precisely. However, this 
theoretic oncern is less likely to be actually important in the 
current study: 1) In our institution, an echocardiographic study is 
almost always acquired before intervention; therefore, interven- 
tion does not cause loss of foUow-up. For example, we reviewed 
the records of 65 consecutive patients undergoing surgical or 
catheter interventions from our institutional data base of 
cardiac procedures; of these 65 patients, 60 had an echocar- 
diogram within the month before the intervention, and 63 
within the preceding 3 months. Thus, having two echocardio- 
graphic studies did not importantly select against hose under- 
going intervention. 2) The study group comprised a reasonable 
spectrum of mitral stenosis everity: As >40% had an MVA 
<1.5 cm 2, moderate to severe disease was not excluded. 
However, patients with more progressive disease might be 
expected to have more frequent follow-up and thus be over- 
represented. Despite this possibility, two thirds of our study 
patients belonged to the group without progression of disease, 
a proportion similar to that reported by Gordon et al. (4); this 
combination of patients with and without progression should 
also allow a reasonable assessment of risk factors by multivar- 
iate analysis. Nevertheless, a prospective natural history would 
be necessary to limit the potential for such biases in either 
direction. 
Clinical implications. The present study represents the 
largest group of patients with mitral stenosis studied by 
two-dimensional nd Doppler echocardiography over a long 
period of time and adds important information regarding the 
progression of mitral stenosis, including the progression of 
right heart disease and the influence of associated valvular 
lesions. The finding that the rate of progression of mitral 
stenosis is variable among patients uggests that follow-up by 
echocardiography is a reasonable measure to determine such 
progression for all patients with mitral stenosis regardless of 
severity because the rate of progression does not seem to be 
predictable by any of the variables tested. (Such objective 
follow-up information is widely used, for example, to explore 
symptomatic changes because of the lack of good correlation 
between symptoms and objective hemodynamic measures.) 
Follow-up appears particularly important in patients with 
associated aortic regurgitation, in whom mitral stenosis pro- 
gressed more rapidly. Because changes in right heart disease, 
an important factor in determining intervention, can be de- 
tected by echocardiography and can occur independent of 
changes in MVA, monitoring of these changes in addition to 
the change in MVA could potentially be helpful for decision- 
making regarding the ideal time for intervention. 
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